Thirty Years of Statins Festschrift in honor of Dr. Akira Endo - Introductory remarks

被引：5
作者：
Yamamoto, A [1 ]
机构：
[1] Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 565, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 03期
关键词：
D O I：
10.1016/j.atherosclerosissup.2004.08.005
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 12 条
[1]   MEVINOLIN AND COLESTIPOL STIMULATE RECEPTOR-MEDIATED CLEARANCE OF LOW-DENSITY LIPOPROTEIN FROM PLASMA IN FAMILIAL HYPERCHOLESTEROLEMIA HETEROZYGOTES [J].
BILHEIMER, DW ;
GRUNDY, SM ;
BROWN, MS ;
GOLDSTEIN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13) :4124-4128
[2]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[3]   COMPETITIVE INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE BY ML-236A AND ML-236B FUNGAL METABOLITES, HAVING HYPOCHOLESTEROLEMIC ACTIVITY [J].
ENDO, A ;
KURODA, M ;
TANZAWA, K .
FEBS LETTERS, 1976, 72 (02) :323-326
[4]   ML-236A, ML-236B, AND ML-236C, NEW INHIBITORS OF CHOLESTEROGENESIS PRODUCED BY PENICILLIUM CITRINUM [J].
ENDO, A ;
KURODA, M ;
TSUJITA, Y .
JOURNAL OF ANTIBIOTICS, 1976, 29 (12) :1346-1348
[5]  
GAW A, 2000, HMG COA REDUCTASE IN
[6]  
Moore TJ., 1989, Atl Mon, V264, P37
[7]   LOWER PATIENTS CHOLESTEROL NOW - TRIAL EVIDENCE SHOWS CLEAR BENEFITS FROM SECONDARY PREVENTION [J].
OLIVER, M ;
POOLEWILSON, P ;
SHEPHERD, J ;
TIKKANEN, MJ .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 310 (6990) :1280-1281
[8]   MIGHT TREATMENT OF HYPERCHOLESTEROLEMIA INCREASE NONCARDIAC MORTALITY [J].
OLIVER, MF .
LANCET, 1991, 337 (8756) :1529-1531
[9]  
PEDERSEN TR, 1994, LANCET, V344, P1383
[10]   Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals [J].
Shepherd, J ;
Hunninghake, DB ;
Barter, P ;
McKenney, JM ;
Hutchinson, HG .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A) :11C-17C
12